EcoDrugPlus

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSAPEG00000004946
Gene Symbol: PTGFR
1 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSAPEG00000010934
Gene Symbol: PTGIR
1 Cross references
188 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSAPEG00000020917
Gene Symbol: PTGS1
1 Cross references
196 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSAPEG00000011702
Gene Symbol: PTGS1
1 Cross references
196 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2b

Ensembl ID : ENSAPEG00000008879
Gene Symbol: PTGS2B
1 Cross references
213 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSAPEG00000010541
Gene Symbol: PSMA1
1 Cross references
271 Possible Orthologues:

Proteasome 20s Subunit Alpha 2a

Ensembl ID : ENSAPEG00000018372
Gene Symbol: PSMA2A
1 Cross references
278 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSAPEG00000001270
Gene Symbol: PSMA3
1 Cross references
252 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSAPEG00000012616
Gene Symbol: PSMA4
2 Cross references
199 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSAPEG00000001679
Gene Symbol: PSMA4
1 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSAPEG00000006452
Gene Symbol: PSMA5
1 Cross references
212 Possible Orthologues:

Proteasome 20s Subunit Alpha 6a

Ensembl ID : ENSAPEG00000002018
Gene Symbol: PSMA6A
1 Cross references
229 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).